Psilocybin for nicotine cravings in young e-cigarette users
Treatments studied
Part of Mental health clinical trials.
This study tests whether psilocybin, a psychedelic substance, can reduce cravings for nicotine in people who vape regularly. If you qualify, you'll receive psilocybin in a controlled setting and have brain scans to see how it affects your cravings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 35 years old.
- You are already part of the UBC SCANS study (H24-02776).
- You have been vaping nicotine at least 5 days a week for the past year.
- You have moderate nicotine dependence (the study team will confirm).
- You are comfortable with a saliva test to confirm your vaping status.
- You are willing to abstain from nicotine for at least 12 hours and from other substances (except caffeine) for at least 24 hours before sessions.
- You are not currently trying to quit or cut down on vaping.
- You can speak and understand English.
- If you can become pregnant, you must have a negative pregnancy test and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.
This study looks at how young adults who vape react to oral nicotine pouches (like Zyn). It tests whether these products might be appealing or lead to misuse. You must be 21–25, an exclusive vaper, and never have used nicotine pouches before.
This Phase 1 study tests how a synthetic nicotine product is absorbed and how the body responds (so researchers can better understand nicotine effects and handling). You may be able to join if you’re generally healthy and regularly use e-cigarettes, but you’ll need to avoid certain medicines and nicotine products during the study.
This study tests a program to help young adults who use both nicotine and cannabis products reduce or quit nicotine use. If you are between 18 and 25, use nicotine products at least 20 days a month and cannabis at least 10 days a month, and want to quit nicotine, you may be eligible.
This program is for teens aged 14 to 19 who vape at least once a week and want to quit or cut back. It tests a behavioral support approach to help them stop using nicotine vapes.
This Phase 2 study tests whether a psilocybin “session” with niacin can help people quit smoking. It’s for adults who smoke daily and want to quit but have tried and struggled before.
Hear when a new Nicotine Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.